CEBPD and breast carcinoma: In contrast, cells with high basal levels of C/EBPδ [18, 21], such as the breast cancer cells SUM149 and SUM159, and mammary epithelial cell lines (MCF-10A and MCF-12A) rather reduced its expression in response to thapsigargin (Fig. S1e–h).